RIPE-KG · Version 1.1.0 · Resource
ripekg:work/RIPEW82206C1C95CA4206
https://w3id.org/ripe/ripe-kg/work/RIPEW82206C1C95CA4206
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW82206C1C95CA4206Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments |
ripekg:work/RIPEW82206C1C95CA4206Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments |
dcterms:title |
Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments |
ripekg:work/RIPEW82206C1C95CA4206Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments |
rdf:type |
node1 |
ripekg:work/RIPEW82206C1C95CA4206Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/RIPEW82206C1C95CA4206Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments |
rdf:type |
rdfs:Resource |
ripekg:work/RIPEW82206C1C95CA4206Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments |
rdf:type |
owl:Thing |
ripekg:work/RIPEW82206C1C95CA4206Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments |
rdf:type |
prov:Entity |
ripekg:work/RIPEW82206C1C95CA4206Glutamatergic neurotransmission: pathway to developing novel rapid-acting antidepressant treatments |
rdf:type |
ripe:WorkWork |